Systemic treatment for oesophageal cancer

European Journal of Cancer

Volumn 41, Issue 5, 2005, Pages 664-672

  Van Meerten, Esther ^a   Van Der Gaast, Ate ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chemoradiotherapy; Chemotherapy; Combined modality treatment; Oesophageal carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CELECOXIB; CETUXIMAB; CISPLATIN; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; EPIRUBICIN; ETOPOSIDE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; IRINOTECAN; METHOTREXATE; MITOMYCIN; OXALIPLATIN; PACLITAXEL; TAXANE DERIVATIVE; VINDESINE;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG TOLERABILITY; DYSPHAGIA; ESOPHAGUS CARCINOMA; HUMAN; META ANALYSIS; METASTASIS; MORBIDITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SIDE EFFECT; SURGICAL TECHNIQUE; THORACOTOMY; TREATMENT OUTCOME;

EID: 14844318584     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.10.030     Document Type: Article

References (86)

1. D.M. Parkin, F.I. Bray, and S.S. Devesa Cancer burden in the year 2000. The global picture Eur J Cancer 37 2001 S4 S66
2. W.J. Blot, and J.K. McLaughlin The changing epidemiology of esophageal cancer Semin Oncol 26 1999 2 8
3. W.H. Chow, W.J. Blot, and T. Vaughn Body mass index and risk of adenocarcinoma of the esophagus and gastric cardia J Natl Cancer Inst 90 1998 150 155
4. J. Lagergren, R. Bergstrom, and A. Lindgren Symptomatic gastro-esophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 1999 825 831
5. J.A. Jankowski, N.A. Wright, and S.J. Meltzer Molecular evolution of the metaplasia-dysplasia-adenoma sequence in the esophagus (MCS) Am J Pathol 154 1999 965 974
6. J.B. Hulscher, J.W. van Sandick, and A.G. de Boer Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus N Engl J Med 347 2002 1662 1669
7. K.W. Millikan, J. Silverstein, and V. Hart A 15-year review of esophagectomy for carcinoma of the esophagus and cardia Arch Surg 130 1995 617 624
8. D.P. Kelsen, and D.H. Ilson Chemotherapy and combined-modality therapy for esophageal cancer Chest 107 1995 224S 232S
9. A.D. Hilgenberg, R.W. Carey, and E.W. Wilkins Jr. Preoperative chemotherapy, surgical resection and selective postoperative therapy for squamous cell carcinoma of the esophagus Ann Thorac Surg 45 1988 357 363
10. M.B. Polee, H.W. Tilanus, and F.A.L.M. Eskens Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus Ann Oncol 14 2003 1253 1257
11. K. Nygaard, S. Hagen, and H.S. Hansen Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer World J Surg 16 1992 1104 1109
12. J.A. Roth, H.I. Pass, and M.M. Flanagan Randomized clinical trial of pre-operative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus J Thorac Cardiovasc Surg 96 1988 242 248
13. P. Schlag Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft für Onkologie der Deutschen Gesellschaft für Chirurgie Study Group Arch Surg 127 1992 1446 1450
14. T. Maipang, P. Vasinanukorn, and C. Petpichetchian Induction chemotherapy in the treatment of patients with carcinoma of the esophagus J Surg Oncol 56 1994 191 197
15. X. Pouliquen, H. Levard, and J.M. Hay 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Associations for Surgical Research Ann Surg 223 1996 127 133
16. N. Ando, T. Iizuka, and T. Kakegawa A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study J Thorac Cardiovasc Surg 114 1997 205 209
17. S. Law, M. Fok, and S. Chow Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial J Thorac Cardiovasc Surg 114 1997 210 217
18. T.C. Kok, J. van Lanschot, and P.D. Siersema Neoadjuvant chemotherapy in operable squamous cell cancer of the esophagus: final report of a phase III multicenter randomised trial Proc Am Soc Clin Oncol 17 1997 984
19. D.P. Kelsen, R. Ginsberg, and T.F. Pajak Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med 339 1998 1979 1984
20. E. Ancona, A. Ruol, and S. Santi Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone Cancer 91 2001 2165 2174
21. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in esophageal cancer: a randomised controlled trial. Lancet 2002, 359, 1727-1733
22. Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer (Cochrane Review). In The Cochrane Library, Issue 3, 2004. Oxford: Update Software
23. J.D. Urschel, H. Vasan, and C.J. Blewett A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer Am J Surg 183 2002 274 279
24. N. Ando, and T. Iizuka Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204 J Clin Oncol 21 2003 4592 4596
25. I.F. Tannock Treatment of cancer with radiation and drugs J Clin Oncol 14 1996 3156 3174
26. J.H. Kim, E.K. Choi, and S.B. Kim Preoperative hyperfractionated radiotherapy with concurrent chemotherapy in resectable esophageal cancer Int J Radiat Oncol Biol Phys 50 2001 1 12
27. F. De Vita, N. Di Martino, and M. Orditura Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus. A phase II study Chest 122 2002 1302 1308
28. E. Poplin, T. Fleming, and L. Leichman Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037) J Clin Oncol 5 1987 622 628
29. A.A. Forastiere, M.B. Orringer, and C. Perez-Tamayo Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report J Clin Oncol 11 1993 1118 1123
30. M.S. Bhansali, J.S. Vaidya, and R.G. Bhatt Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analyses of randomized trials and of historical control studies Ann Oncol 7 1996 355 359
31. C. Apinop, P. Puttisak, and N. Preecha A prospective study of combined therapy in esophageal cancer Hepatogastroenterology 41 1994 391 393
32. E. Le Prise, P.L. Etienne, and B. Meunier A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus Cancer 73 1994 1779 1784
33. J.F. Bosset, M. Gignoux, and J.P. Triboulet Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 337 1997 161 167
34. T.N. Walsh, N. Noonan, and D. Hollywood A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 1996 462 467
35. S.G. Urba, M.B. Orringer, and A. Turrisi Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 2001 305 313
36. F. Fiorica, D. Di Bona, and F. Schepis Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis Gut 53 2004 925 930
37. I.G. Kaklamanos, G.R. Walker, and K. Ferry Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials Ann Surg Oncol 10 2003 754 761
38. J.D. Urschel, and H. Vasan A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer Am J Surg 185 2003 538 543
39. L. Bedenne, P. Michel, and J.-P. Bouche Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102) Proc Am Soc Clin Oncol 21 2002 130a
40. M. Stahl, H. Wilke, and M.K. Walz Randomized phase III trial in locally advanced squamous cell carcinoma (SCC) of the esophagus: chemoradiation with and without surgery Proc Am Soc Clin Oncol 22 2003 250
41. P. Flamen, E. Van Cutsem, and A. Lerut Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer Ann Oncol 13 2002 361 368
42. H. Kato, H. Kuwano, and M. Nakajima Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer Am J Surg 184 2002 279 283
43. R.J. Downey, T. Akhurst, and D. Ilson Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial J Clin Oncol 21 2003 428 432
44. 18F-Fluorodeoxyglucose positron emission tomography in esophageal cancer J Clin Oncol 22 2004 3805 3812
45. D.J. Adelstein, T.W. Rice, and L.A. Rybicki Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy J Clin Oncol 18 2000 2032 2039
46. D.H. Ilson, M. Bains, and D.P. Kelsen Phase I trail of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer J Clin Oncol 21 2003 2926 2932
47. D.H. Ilson, and B. Minsky Irinotecan in esophageal cancer Oncology (Huntingt) 17 2003 S32 S36
48. S.G. Urba, M.B. Orringer, and M. Ianettonni Concurrent cisplatin, paclitaxel and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma Cancer 98 2003 2177 2183
49. S.R. Smalley, L.L. Gunderson, and E.K. Reddy Radiotherapy alone in esophageal carcinoma: current management and future directions of adjuvant, curative and palliative approaches Semin Oncol 21 1994 467 473
50. A. Roussel, H. Bleiberg, and O. Dalesio Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial Int J Radiat Oncol Biol Phys 16 1989 67 72
51. J.C. Zhou Randomized trial of combined chemotherapy including high dose cisplatin and radiotherapy for esophageal cancer Zhongua Zzhong Liu Za Zhi 13 1991 291 294 (Chinese)
52. Y. Hishikawa, T. Miura, and T. Oshitani A randomized prospective study of adjuvant chemotherapy after radiotherapy in unresectable esophageal carcinoma Dis Esophagus 4 1991 85 90
53. R. Hatlevoll, S. Hagen, and H.S. Hansen Bleomycin/cis-platin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus. A prospective randomized multicentre study - the second Scandinavian trial in esophageal cancer Radiother Oncol 24 1992 114 116
54. X.J. Lu, R.H. Miao, and X.Q. Li Combination of selective arterial infusion chemotherapy with radiotherapy in the treatment of advanced esophageal carcinoma Chin J Clin Oncol 22 1995 262 265 (Chinese)
55. J.D. Earle, R.D. Gelber, and C.G. Moertel A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus Int J Radiat Oncol Biol Phys 6 1980 821 826
56. Z.F. Zhang Radiation combined with bleomycin in esophageal carcinoma- a randomized study of 99 patients Zhongua Zhong Liu Za Zhi 6 1984 372 374 (Chinese)
57. A.P. Andersen, P. Berdal, and F. Edsmyr Irradiation, chemotherapy and surgery in esophageal cancer: a randomized clinical study. The first Scandinavian trial in esophageal cancer Radiother Oncol 2 1984 179 188
58. C.M. Araujo, L. Souhami, and R.A. Gil A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus Cancer 67 1991 2258 2261
59. A. Roussel, P. Haegele, and B. Paillot Results of the EORTC GTCCG phase III trial of irradiation versus irradiation and CDDP in inoperable esophageal cancer Proc Am Soc Clin Oncol 13 1994 199 [abstract]
60. T. Kaneta, Y. Takai, and K. Nemoto Effect of combination chemotherapy with daily low-dose CDDP for esophageal cancer: results of a randomized trial Jpn J Cancer Chemother 24 1997 2099 2104
61. C.F. Slabber, J.S. Nel, and L. Schoeman A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus Am J Clin Oncol 21 1998 462 465
62. J.S. Cooper, M.D. Guo, and A. Herskovic Chemoradiotherapy of locally advanced esophageal cancer: long term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group JAMA 281 1999 1623 1627
63. A. Herskovic, K. Martz, and M. Al-Sarraf Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 1992 1593 1598
64. B.D. Minsky, T.F. Pajak, and R.J. Ginsberg Int. 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy J Clin Oncol 20 2002 1167 1174
65. Th. Wobbes, B. Baron, and B. Paillot Prospective randomized study of split-course radiotherapy in inoperable squamous cell carcinoma of the esophagus Eur J Cancer 37 2001 470 479
66. R. Wong, and R. Malthaner Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus (Cochrane Review) Cochrane Database Syst Rev 2 2001 CD002092
67. T.A. Rich, and R. Shepard COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: esophagus, stomach, and pancreas Am J Clin Oncol 26 2003 S110 S113
68. Z. Liao, L. Milas, and R. Komaki Combination of a COX-2inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer Am J Clin Oncol 26 2003 S85 S91 (review)
69. J.A. Bonner, P.M. Harari, and J. Giralt Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: a phase III study of high dose radiation therapy with or without cetuximab Proc Am Soc Clin Oncol 23 2004 5507 (abstract)
70. C.H. Spiridonidis, L.R. Laufman, and J.J. Jones A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinoma Cancer 78 1996 2070 2077
71. D.H. Ilson, A. Forastiere, and M. Arquette A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus Cancer J 6 2000 316 323
72. M.Y. Homs, M.L. Essink-Bot, and G.J. Borsboom Dutch SIREC Study Group. Quality of life after palliative treatment for oesophageal carcinoma - A prospective comparison between stent placement and single dose brachytherapy Eur J Cancer 40 2004 1862 1871
73. D.H. Ilson Oesophageal cancer: new developments in systemic therapy Cancer Treat Rev 29 2003 525 532 (review)
74. M.B. Polee, F.A.L.M. Eskens, and M.E.L. van der Burg Phase II study of weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer Br J Cancer 46 2002 669 673
75. D.H. Ilson, L. Saltz, and P. Enzinger Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer J Clin Oncol 17 1999 3270 3275
76. M.B. Polee, W.C.J. Hop, and T.C. Kok Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy Br J Cancer 89 2003 2045 2050
77. I. Chau, A.R. Norman, and D. Cunningham Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data J Clin Oncol 22 2004 2395 2403
78. N. Nicolaou, and A.A. Conlan Cyclophosphamide, doxorubicin and Celestin intubation for inoperable oesophageal carcinoma S Afr Med J 61 1982 428 431
79. H. Levard, X. Pouliquen, and J.M. Hay 5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma. A multicentre randomised controlled trial. The French Associations for Surgical Research Eur J Surg 164 1998 849 857
80. H. Bleiberg, T. Conroy, and B. Paillot Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer Eur J Cancer 33 1997 1216 1220
81. E.Z. Edzinli, R. Gelber, and D.V. Desai Chemotherapy of advanced esophageal carcinoma: Eastern Cooperative Oncology Group experience Cancer 46 1980 2149 2153
82. A. Webb, D. Cunningham, and J.H. Scarffe Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer J Clin Oncol 15 1997 261 267
83. J.S. Waters, A. Norman, and D. Cunningham Long-term survival after epirubibin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial Br J Cancer 80 1999 269 272
84. P. Ross, M. Nicolson, and D. Cunningham Prospective randomized trial comparing mitomycin, cisplatin and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin and PVI 5-FU in advanced esophagogastric cancer J Clin Oncol 20 2002 1996 2004
85. N.C. Tebbutt, A. Norman, and C. Cunningham A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer Ann Oncol 12 2002 1568 1575
86. A.J. Munro Oesophageal cancer: a view over overviews Lancet 364 2004 566 568